Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice

American Journal of Transplantation

Volumn 12, Issue 5, 2012, Pages 1124-1132

  Shi, Q ^a   Lees, J R ^a   Scott, D W ^a   Farber, D L ^a   Bartlett, S T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antilymphocyte antibodies; autoimmunity; diabetes mellitus; donor T cell; islet cells; NOD mice; regulatory cells

Indexed keywords

LYMPHOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; ENGRAFTMENT; FEMALE; GRAFT SURVIVAL; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; ORGAN DONOR; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; T CELL DEPLETION;

ANIMALS; ANTILYMPHOCYTE SERUM; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT SURVIVAL; IMMUNOENZYME TECHNIQUES; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPH NODES; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 84860449771     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03943.x     Document Type: Article

References (43)

1. Shapiro AM, Lakey JR, Ryan EA, et al,. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
2. Ryan EA, Paty BW, Senior PA, et al,. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069.
3. Johansson H, Goto M, Dufrane D, et al,. Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006; 6: 305-312.
4. Laughlin E, Burke G, Pugliese A, Falk B, Nepom G,. Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation. Clin Immunol 2008; 128: 23-30.
5. Monti P, Scirpoli M, Maffi P, et al,. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest 2008; 118: 1806-1814.
6. Stegall MD, Lafferty KJ, Kam I, Gill RG,. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 1996; 61: 1272-1274.
7. Vendrame F, Pileggi A, Laughlin E, et al,. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010; 59: 947-957.
8. Guo Z, Mital D, Shen J, et al,. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation 1998; 65: 1310-1314.
9. Wu AJ, Hua H, Munson SH, McDevitt HO,. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci U S A 2002; 99: 12287-12292.
10. Tang Q, Henriksen KJ, Bi M, et al,. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465.
11. Baecher-Allan C, Hafler DA,. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006; 212: 203-216.
12. Szanya V, Ermann J, Taylor C, Holness C, Fathman CG,. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 2002; 169: 2461-2465.
13. D'Alise AM, Auyeung V, Feuerer M, et al,. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci U S A 2008; 105: 19857-19862.
14. Berney T, Ferrari-Lacraz S, Buhler L, et al,. Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: Over the 10-year mark. Am J Transplant 2009; 9: 419-423.
15. Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH,. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J Immunol 2008; 181: 7350-7355.
16. Karakhanova S, Munder M, Schneider M, Bonyhadi M, Ho AD, Goerner M,. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. J Immunother 2006; 29: 336-349.
17. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al,. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005; 352: 2598-2608.
18. International Pancreas Transplant Registry Annual Report, University of Minnesota; 2004.
19. Shi Q, Wang D, Hadley GA, Bingaman AW, Bartlett ST, Farber DL,. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity. Diabetes 2004; 53: 2338-2345.
20. Shi Q, Wang D, Hadley GA, Farber DL, Bartlett ST,. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4. Surgery 2006; 140: 281-288.
21. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY,. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22: 329-341.
22. Tang AL, Teijaro JR, Njau MN, et al,. CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis. J Immunol 2008; 181: 1806-1813.
23. Zhou X, Jeker LT, Fife BT, et al,. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008; 205: 1983-1991.
24. Tzakis AG, Ricordi C, Alejandro R, et al,. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 1990; 336: 402-405.
25. Group WHIT. Autoimmunity after islet-cell allotransplantation. N Engl J Med 2006; 355: 1397-1399.
26. Bromberg JS, LeRoith D,. Diabetes cure-is the glass half full? N Engl J Med 2006; 355: 1372-1374.
27. Bartlett ST, Hadley GA, Dirden B, et al,. Composite kidney-islet transplantation prevents recurrent autoimmune beta-cell destruction. Surgery 1993; 114: 211-217.
28. Bartlett ST, Chin T, Dirden B, Quereshi A, Hadley G,. Inclusion of peripancreatic lymph node cells prevents recurrent autoimmune destruction of islet transplants: Evidence of donor chimerism. Surgery 1995; 118: 392-397; discussion 397-398.
29. Luo X, Tarbell KV, Yang H, et al,. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 2007; 104: 2821-2826.
30. Long SA, Walker MR, Rieck M, et al,. Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects. Eur J Immunol 2009; 39: 612-620.
31. Velasquez-Lopera MM, Eaton VL, Lerret NM, et al,. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells. Transpl Immunol 2008; 19: 127-135.
32. Minamimura K, Gao W, Maki T,. CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody. J Immunol 2006; 176: 4125-4132.
33. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N,. A novel mechanism of action for anti-thymocyte globulin: Induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 2006; 17: 2844-2853.
34. Feng X, Kajigaya S, Solomou EE, et al,. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3 +regulatory T cells in vitro. Blood 2008; 111: 3675-3683.
35. Yamanouchi J, Rainbow D, Serra P, et al,. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007; 39: 329-337.
36. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D,. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009; 31: 654-664.
37. Tian B, Hao J, Zhang Y, et al,. Upregulating CD4+CD25+FOXP3 +regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Transplantation 2009; 87: 198-206.
38. Simon G, Parker M, Ramiya V, et al,. Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation. Diabetes 2008; 57: 405-414.
39. Liu B, Hao J, Pan Y, et al,. Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion. Am J Transplant 2006; 6 (Pt 1): 933-946.
40. Nikolic B, Onoe T, Takeuchi Y, et al,. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice. Transplantation 89: 23-32.
41. Wu T, Levay-Young B, Heuss N, et al,. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 2002; 74: 22-27.
42. Kroon E, Martinson LA, Kadoya K, et al,. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008; 26: 443-452.
43. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA,. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008; 455: 627-632.